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Background:Anxiety is often present in patientswith depression. The aimof this studywas to evaluate the
impact of clustered depression and anxiety on mortality and rehospitalization in hospitalized patients
with heart failure (HF).
Methods: A total of 221 hospitalized patients with HF, who completed the questionnaires, were analyzed
in this prospective study (mean age 62±13 years; 28% female). One-third patients had implanted cardiac
devices. Depression was deﬁned as a Zung Self-Rating Depression Scale index score of ≥60 and anxiety
was deﬁned as a State-Trait Anxiety Inventory score of ≥40 (male) or ≥42 (female). The primary outcome
was the composite of death from any cause or rehospitalization due to worsened HF and refractory
arrhythmia.
Results:Of the 221HF patients, 29 (13%) had depression alone, 80 (36%) had anxiety alone, and 46 patients
(21%) had both depression and anxiety. During an average follow-up of 41±21 months, patients with
depression alone and those with clustered depression and anxiety were at an increased risk of the pri-
mary outcome [hazard ratio (HR) 2.24, 95% conﬁdence interval (CI): 1.17–4.28, p=0.01 and HR 2.75, 95%
CI: 1.51–4.99, p=0.01, respectively] compared to patients with no symptoms. Multivariate analysis after
adjusting for age, gender, New York Heart Association functional class, B-type natriuretic peptide, device
implantation, renal dysfunction, and left ventricular dysfunction showed clustered depression and anx-
iety, but not depression alone or anxiety alone, was an independent predictor of the primary outcome
(HR 1.96, 95% CI: 1.00–3.27, p=0.04).
Conclusions: Our results showed that clustered depression and anxiety were associated with worse out-
comes in patients with HF.
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morbidity and mortality [1]. The psychological issues, particularly
emotional distress including depression and anxiety, are common
in patients with HF [1–5]. Several studies have focused on the role
of depression and suggested that depression is a possible risk fac-
tor for adverse outcomes in patients with HF [4–7]. The prevalence
of depression is reported to be approximately 15–40% in patients
withHF, anddepression is independently associatedwith poor out-
comes [5–13]. A meta-analysis showed that depression is common
among patients with HF, and substantially higher rates of clini-
cally signiﬁcant depression are present among patients with more
severe HF [4].
There have been fewer studies regarding anxiety in patients
with HF. A previous report showed that 18.4% of patients with
served.
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F had an anxiety disorder [14]. Another report showed that the
core for anxiety symptoms was higher in patients with HF than
n healthy controls [15]. However, this issue has remained contro-
ersial [1]. In some studies, no association has been found between
nxiety symptoms and cardiac events in patients with HF [16–19].
Recently, van den Broek et al. [20] focused on the impact
f clustering psychosocial risk factors on clinical outcomes in
atients with implantable cardioverter deﬁbrillators (ICDs) and
howed that ICD patients with both anxiety and Type D per-
onality were at an increased risk of ventricular arrhythmia. In
hat study, the risk factors were clustered because psychologi-
al risk factors often occurred together, but not individually, and
he clustering of psychological risk factors may pose a high-risk
actor for clinical events than would a single risk factor in car-
iac patients [20,21]. Although depression and anxiety have been
iscussed separately as psychological factors, they frequently clus-
er within a patient [22]. The signs and symptoms of anxiety are
ften present in patients with depression, and the two condi-
ions may play a partial role in a pathophysiological process of
F [23]. Some studies have shown that the clustered depression
nd anxiety worsened patients’ health status following myocar-
ial infarction or percutaneous coronary intervention [24,25]. From
his viewpoint, clustered depression and anxiety may be clini-
ally valuable as an indicator of psychological distress in patients
ith HF. However, a few studies have investigated this issue. The
im of this study was to evaluate the effect of clustered depres-
ion and anxiety on mortality and rehospitalization in patients
ith HF.
ethods
We conducted a substudy of the prospective observational
tudy comprising hospitalized patients with cardiovascular dis-
ase, who were admitted to the Cardiology Department of Tokyo
omen’sMedical UniversityHospital between June 2006 andApril
008. Patients with dementia, delirium, or other conditions (e.g.
nconsciousness, intensive care, and end stage of another life-
hreatening disease) that make completing self-reported written
uestionnaires difﬁcult were excluded. Among them, 221 patients
ith a New York Heart Association (NYHA) functional class ≥2 on
dmission, who were diagnosed with HF, and who completed the
uestionnaires were included in this study (Fig. 1). The details of
609 hospitalized patients who
had a NYHA functional class
≥ 2 on admission
(June 2006~April 2008)
 
197 excluded due to 
       intensive care,  
       dementia, delirium,     
       or unconsciousness 
412 patients assessed  
for eligibility 
92 incomplete responses 
22 withdrew consent     
390 patients enrolled 
221 patients available 
77 uncollected questionnaires          
Fig. 1. The ﬂow diagram of study subjects. NYHA, New York Heart Association.ology 64 (2014) 456–462 457
the study have been reported elsewhere [26]. The protocol was
approvedby the institutional reviewboardof TokyoWomen’sMed-
ical University. All patients gave written informed consent.
Assessment of depression and anxiety
The majority of patients received the psychological question-
naires within 3 days (2±1 days) after their admission to the
hospital. For patients who initially required intensive treatment,
these questionnaires were received after their transfer to the gen-
eral cardiology ward. The Zung Self-Rating Depression Scale (SDS)
was used to screen for depression and to measure the severity of
the depression in a number of settings [27–31]. The Zung SDS is
a self-reported scale containing 20 questions that assess the psy-
chological and somatic symptoms. The Zung SDS score has been
reported to be a primary discriminating variable in distinguish-
ingdepressed fromnon-depressedpersonsand indicates likelihood
ratio positive for major depression as 3.3 [95% conﬁdence interval
(CI): 1.3–8.1] and likelihood ratio negative as 0.35 (95% CI: 0.2–0.8)
[29]. The Zung SDS score has also been used to assess depression in
clinical studies on cardiovascular diseases [32–36]. A cutoff index
score of 60 has been shown to detect clinical depression while
avoiding an abundance of false positives in sick patients [37–40].
In this study, depression was deﬁned as a Zung SDS index score
of ≥60.
The State-Trait Anxiety Inventory (STAI) was used to measure
anxiety symptoms [41]. In this study, only the state-scale mea-
surement was used because state anxiety is characterized as a
temporary change in each patient’s emotional state due to med-
ical illness or other external cause, the measurement has also been
used in clinical studies on cardiovascular diseases [16,20,42]. The
STAI comprises 20 items, and each item is scored on a four-point
scale from 1 (not at all) to 4 (very much so). The STAI scores range
from 20 to 80, with higher scores indicating greater levels of anxi-
ety. Anxiety was deﬁned as a score of ≥40 (male) or ≥42 (female)
[43,44].
Follow-up
Afterdischarge, patientswere seenasoutpatients at ourhospital
or their general practitioner’s clinic at 1- to 3-month intervals until
October 2011. Patients receiving pacing device therapy, includ-
ing pacemakers, cardiac resynchronization therapy (CRT), and ICD,
were also followed every 3–6 months at our pacemaker/ICD clinic.
The information about deceased patients was obtained from the
medical records, family members, their general practitioners, and
the admitting hospital.
Clinical outcomes
The primary outcome was the composite of death from any
cause and rehospitalization due to worsened HF and refractory
arrhythmia from the time of enrollment to the ﬁrst event. Wors-
ened HF was deﬁned by signs and symptoms, such as dyspnea,
rales, and ankle edema, as well as by the need for treatment with
diuretics, vasodilators, positive inotropic drugs, or an intra-aortic
balloon pump. Refractory arrhythmia was deﬁned as supraven-
tricular or ventricular tachyarrhythmia that required external
deﬁbrillationorpacing, intravenous antiarrhythmics, such as amio-
darone and nifekalant, catheter ablation, or implantation of an
ICD, or bradyarrhythmia that required implantation of a pace-
maker. Both supraventricular and ventricular arrhythmias are
common in patients with HF, and cause symptoms, hemodynamic
instability, andmorbidities such as stroke and suddendeath. There-
fore, we included rehospitalization for refractory arrhythmia in
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he primary endpoint. The second outcome was death from any
ause.
ata analysis
The data are presented as eithermean± standard deviation (SD)
r number of patients. We created four groups on the basis of
epression and anxiety: (1) depression alone, (2) anxiety alone,
3) clustered depression and anxiety, and (4) no symptoms (no
epression nor anxiety). Baseline clinical data were compared
etween the groups using analysis of variance (ANOVA). The Cox
roportional hazards model was used to assess the relationship of
epression, anxiety, and the cluster of both with clinical outcomes.
e ﬁrst assessed the unadjusted relationship of the following
ariables at discharge with the primary outcome: female gender,
ge ≥65 years, NYHA functional class, plasma B-type natriuretic
eptide (BNP) concentration >250pg/ml [45,46], implantation of
n ICD/CRT with a deﬁbrillator (CRT-D), left ventricular ejec-
ion fraction (LVEF) ≤35%, estimated glomerular ﬁltration rate
eGFR) by the Modiﬁcation of Diet in Renal Disease formula [47]
60ml/min/1.73m2, depression, anxiety, and clustered depression
nd anxiety. Then, we assessed the relationship of depression,
nxiety, and the cluster of both with the primary outcome after
ontrolling for gender, age ≥65 years, NYHA functional class, BNP
250pg/ml, implantation of an ICD/CRT-D, LVEF ≤35%, and eGFR
60ml/min/1.73m2. The cumulative event-free rates were calcu-
ated using the Kaplan–Meier method. The data analyses were
erformed with SPSS (Statistical Package for the Social Sciences)
tatistical software (version 11.01, SPSS Inc., Chicago, IL, USA). A
-value of <0.05 was considered signiﬁcant.
able 1
atient characteristics.
Depression alone Anxiet
(n=29) (n=80
Age (years) 61±10 62±14
Female 7 (24%) 22 (28
Underlying heart disease
Coronary artery disease 7 (24%) 20 (25
Non-ischemic cardiomyopathy 11 (38%) 23 (29
Valvular heart disease 10 (34%) 20 (25
Congenital heart disease 0 (0%) 1 (1%)
BNP on admission (pg/ml) 269 (84–709) 275 (4
BNP at discharge (pg/ml) 236 (48–826) 242 (1
NYHA functional class on admission (II/III/IV) 25/4/0 67/15/
NYHA functional class at discharge (II/III/IV) 27/2/0 77/3/0
LVEF (%) 35±10 38±12
eGFR (ml/min/1.73m2) 72±36 76±38
Implanted cardiac devices
Pacemaker/CRT-P 3 (10%) 5 (6%)
ICD/CRT-D 7 (24%) 18 (23
Comorbidities
Hypertension 10 (34%) 31 (39
Diabetes 3 (10%) 27 (34
Major depression 1 (3%) 0 (0%)
Medications at discharge
Beta-blockers 21 (72%) 59 (74
ACE inhibitors/ARBs 25 (86%) 69 (86
Spironolactone/eplerenone 16 (55%) 38 (48
Calcium channel blockers 16 (55%) 55 (69
Aspirin 10 (34%) 29 (36
Warfarin 16 (55%) 42 (53
Amiodarone 11 (38%) 22 (28
Antidepressants 1 (3%) 0 (0%)
Married 26 (90%) 73 (91
Employed 13 (45%) 40 (50
alues are n (%) or mean± SD or median (range).
CE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; BNP, B-type
eﬁbrillator; CRT-P, CRT with a pacemaker; eGFR, estimated glomerular ﬁltration rate; I
YHA, New York Heart Association.ology 64 (2014) 456–462
Results
Patients
A total of 221 patients with HF who completed both the Zung
SDS and STAI were included in this analysis. More than half of
the patients (64%) had a non-ischemic etiology, and one-third had
implanted cardiac devices. Five patients (2%) who were diagnosed
with major depression by a psychiatrist had taken antidepressants
(Table 1). In our sample, none of the patients with depression
received non-pharmacological treatment such as cognitive behav-
ior therapy.
Psychological distress and outcomes
Overall, 75 patients (34%) were diagnosed as having depression
and 126 patients (57%) as having anxiety. Among them, 29 patients
(13%) had depression alone, 80 patients (36%) had anxiety alone,
and 46 patients (21%) had both depression and anxiety (Table 1).
During an average follow-up of 41±21 months, 69 patients
(31%) met the primary outcome: 31 patients died and 38 patients
required rehospitalization due to worsened HF or refractory
arrhythmia. Kaplan–Meier curves for the primary outcome in the
four groups are shown in Fig. 2. Patients with depression alone and
those with clustered depression and anxiety were at an increased
risk of the primary outcome [hazard ratio (HR) 2.24, 95% CI:
1.17–4.28, p=0.01 and HR 2.75, 95% CI: 1.51–4.99, p=0.01, respec-
tively] compared to patients with no symptoms. Causes of death
and rehospitalization are shown in Table 2. Kaplan–Meier curves
for death from any cause are shown in Fig. 3. Patients with clus-
tered depression and anxiety were at an increased risk of death
y alone Depression+ anxiety No symptoms p value
) (n=46) (n=66)
60±12 62±12 0.18
%) 14 (30%) 19 (25%) 0.91
0.01
%) 5 (11%) 39 (59%)
%) 37 (80%) 44 (67%)
%) 2 (4%) 7 (11%)
2 (4%) 2 (3%)
–2254) 349 (8–5271) 152 (4–8454) 0.01
8–1478) 288 (15–2326) 120 (5–4926) 0.01
0 23/22/1 56/10/0 <0.01
30/15/1 64/2/0 <0.01
35±15 39±16 0.21
70±43 80±38 0.16
7 (15%) 7 (11%) 0.20
%) 15 (33%) 15 (23%) 0.16
%) 18 (39%) 25 (38%) 0.16
%) 11 (24%) 28 (42%) 0.05
3 (7%) 1 (2%) 0.04
%) 33 (72%) 43 (65%) 0.76
%) 42 (91%) 59 (89%) 0.57
%) 30 (65%) 31 (47%) 0.15
%) 19 (41%) 43 (65%) <0.01
%) 15 (33%) 33 (50%) 0.09
%) 32 (70%) 22 (33%) 0.11
%) 20 (43%) 9 (14%) <0.01
3 (7%) 1 (2%) 0.16
%) 36 (78%) 64 (97%) <0.01
%) 13 (28%) 34 (52%) 0.04
natriuretic peptide; CRT, cardiac resynchronization therapy; CRT-D, CRT with a
CD, implantable cardioverter deﬁbrillator; LVEF, left ventricular ejection fraction;
T. Suzuki et al. / Journal of Cardiology 64 (2014) 456–462 459
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Depression and Anxiety 
No symptoms
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Depression alone vs  No symptoms HR 2.24 (95%CI 1.17-4.28), P=0.01
Anxiety alone vs  No symptoms HR 1.03 (95%CI 0.58-1.97), P=0.89
Fig. 2. Kaplan–Meier curve for the primary outcome (death from any cause or rehospitalization due to worsened heart failure or refractory arrhythmia) in the four heart
failure patient groups on the basis of depression and anxiety. HR, hazard ratio; CI, conﬁdence interval.
Table 2
Causes of death and rehospitalization for cardiac events.
Depression alone Anxiety alone Depression+ anxiety No symptoms p value
(n=29) (n=80) (n=46) (n=66)
Death from any cause 8 (28%) 4 (5%) 17 (37%) 2 (3%) <0.01
Cardiac death 8 (28%) 4 (5%) 16 (35%) 2 (3%) <0.01
Sudden death 2 (7%) 1 (1%) 1 (2%) 0 (0%) 0.96
Heart failure 6 (21%) 3 (4%) 15 (33%) 2 (3%) <0.01
Non-cardiac death 0 (0%) 0 (0%) 1 (2%) 0 (0%) 0.06
Hospitalization for heart failure 7 (24%) 15 (19%) 5 (11%) 4 (6%) 0.90
(3%)
V
f
p
t
FHospitalization for refractory arrhythmia 3 (10%) 2
alues are n (%).rom any cause (HR 5.59, 95% CI: 2.84–10.90, p<0.01) compared to
atients with no symptoms.
The univariate analysis showed that in addition to NYHA func-
ional class, implantation of an ICD/CRT-D, LVEF ≤35%, BNP at
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ig. 3. Kaplan–Meier curve for death from any cause in the four heart failure patient grou1 (2%) 1 (2%) 0.29discharge >250pg/ml, eGFR <60ml/min/1.73m2, depression alone,
and a combination of depression and anxiety, but not anxi-
ety alone, were signiﬁcant predictors for the primary outcome
(Table 3).
low-up (months) 
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ms HR 5.59 (95%CI 2.84-10.90), P<0.01 
HR 1.85 (95%CI 0.42-8.06), P=0.41 
HR 1.10 (95%CI 0.38-3.16), P=0.85 
Anxiety alone 
Depression alone 
Depression and Anxiety  
No symptoms 
ps on the basis of depression and anxiety. HR, hazard ratio; CI, conﬁdence interval.
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Table 3
Univariate predictors for the primary outcome.
Hazard ratio (95% CI) p value
Female gender 0.70 (0.43–1.15) 0.16
Age ≥65 years 0.89 (0.56–1.42) 0.64
NYHA functional class at discharge 3.97 (2.61–6.04) <0.01
Implantation of an ICD/CRT-D 4.26 (2.56–7.07) <0.01
eGFR <60ml/min/1.73m2 2.88 (1.81–4.59) <0.01
BNP at discharge >250pg/ml 2.95 (1.80–4.81) <0.01
LVEF ≤35% 1.99 (1.24–3.19) <0.01
Depression 2.59 (1.56–4.20) <0.01
Anxiety 1.71 (0.98–2.98) 0.05
Depression and anxiety 2.63 (1.56–4.41) <0.01
BNP, B-type natriuretic peptide; CRT-D, cardiac resynchronization therapy with
a deﬁbrillator; eGFR, estimated glomerular ﬁltration rate; ICD, implantable car-
dioverter deﬁbrillator; LVEF, left ventricular ejection fraction; NYHA, New York
Heart Association.
Table 4
Relationship of depression and anxiety with the primary outcome after adjusting
for age, gender, New York Heart Association class, device implantation, estimated
glomerular ﬁltration rate, B-type natriuretic peptide, and left ventricular ejection
fraction.
Hazard ratio (95% CI) p value
Depression 1.69 (0.97–2.95) 0.06
Anxiety 1.46 (0.80–2.65) 0.21
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The relationship between depression and anxiety with the pri-
ary outcome after adjusting for age, gender, NYHA class, device
mplantation, eGFR, BNP, and LVEF revealed that patientswith clus-
ered depression and anxiety had an increased risk of the primary
utcome, but depression alone was not related to the primary out-
ome (Table 4).
iscussion
Our study revealed that the prevalence of clustered depression
nd anxietywas 20% in hospitalized patientswithHF. Furthermore,
e found that patients with both depression and anxiety were at
n increased risk of the primary composite outcome: death from
ny cause and rehospitalization due to worsened HF and refrac-
ory arrhythmia. Finally, clustered depression and anxiety, but not
epression or anxiety alone, were shown to be independent factors
ssociated with worsening clinical outcomes.
Several studies have shown that depression is an independent
redictor of mortality in patients with HF [1–13]. In our study,
epression was a risk factor in the univariate analysis but was
ot an independent factor after adjusting for clinical variables at
ischarge related to the primary outcome. There are a number of
ossible reasons for the differences in our results compared with
hose in the previous reports. First, our study had a high preva-
ence (one-third) of patients with an ICD/CRT-D. At present, an
CD is the principle therapy in HF patients for preventing sudden
ardiac death. It is increasingly used due to the extended indi-
ation for primary prevention. However, ICD-speciﬁc problems,
uch as frequent shocks and a poor understanding of ICD ther-
py, increase depressive symptoms and reduce the quality of life
or the ICD patients [39,48–50]. Our main study showed that an
CD implantationwas signiﬁcantly associatedwith depression [26].
urthermore, the prevalence of depression increased as the NYHA
unctional class grade increased [4]. In our study, 18 of 23 patients
78%) with NYHA class III/IV at discharge were diagnosed with
epression by the Zung SDS. The presence of an ICD/CRT-D and
YHA functional class III/IV may have confounded the associationology 64 (2014) 456–462
between depression and the primary outcome. Therefore, depres-
sion alone was thought not to be a predictor in this study after
adjusting for multiple variables.
State anxiety is a transient mental or emotional reaction to sev-
eral stressors, includingmedical illness. In a sense, it is thought tobe
a normal reaction in hospitalized patients and an inevitable result
of hospitalization. A Japanese report showed that anxiety has been
reported to be independently associatedwith rehospitalizationdue
toworsenedHF inoutpatientswith stableHF [44].However, in gen-
eral, an association between anxiety and mortality or long-term
cardiac events in patients with HF has not been found [16–19].
Katon et al. suggested that the combination of depression and anx-
iety is associated with poor treatment adherence and increased
medical complications in patients with chronic medical illness,
which may be a severe consequence [51]. Anxiety and depression
are different disorders, and the way in which their mechanisms
may interact in the development of cardiac events or death are not
understood. In the real world, however, psychological factors may
cluster together within individuals to increase the risk of subse-
quent medical events [21]. There is a possibility that patients with
higher psychological distress are selected by combining anxiety
with depression.
In our study, HF was a major cause of death, and the rate of
HF was signiﬁcantly higher in patients with both depression and
anxiety than in those with either depression or anxiety only or
those with no symptoms. Although its pathophysiologic mecha-
nisms are not completely understood, psychological distress may
affect the treatment adherence behavior in patients with HF [52].
Poor adherence to treatment is associated with increased morbid-
ity and mortality in patients with HF [53]. Clustered depression
and anxiety can be a stronger predictive marker of the severity of
the illness or poor prognosis than depression alone in hospitalized
patients with HF. This cluster may also be an important marker
for psychological distress, particularly in hospitalized patients
with HF.
Study limitations
Therewere some limitations in this study. First, thiswasa single-
center cohort study. The clinical characteristics of our patients
might not reﬂect those of general cardiovascular patients with HF.
Second, the patients admitted to our hospital were not consec-
utively enrolled in our main study. Many patients who received
emergent or intensive care were not enrolled because they could
not complete the questionnaires. Third, the questionnaires were
not completed prior to discharge. The primary aim of our main
study was to evaluate the prevalence and distribution of depres-
sion in hospitalized patients. Moreover, the length of the hospital
stay in our patients ranged from a few days to several months
because the severity of HF or comorbiditieswas heterogeneous. For
a long-term prognosis, the assessment just before discharge might
be more appropriate. However, previous studies have demon-
strated that depression at the time of hospitalization, not prior
to discharge, is associated with a poorer prognosis in patients
with cardiovascular disease [54–57]. Fourth, the number of sub-
jects was relatively small. Therefore, subgroup analysis was not
feasible.
Conclusions
Our results showed that clustered depression and anxiety were
predictorsofdeath fromanycauseor rehospitalizationdue towors-
ened HF and refractory arrhythmia in patients with HF. This cluster
may be an important marker for poor outcomes in patients with
HF.
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